期刊文献+

肾癌根治术患者手术前后CD8^+CD28^-T细胞表达及临床意义 被引量:3

Expression and clinical significance of CD8^+CD28^-T cells for renal carcinoma patients underwent nephrectomy
下载PDF
导出
摘要 目的探讨肾癌根治术患者手术前后CD8^+CD28^-T细胞表达及临床意义。方法收集52例接受根治术的肾癌患者作为观察对象,采用流式细胞术检测手术前后外周血CD8^+CD28^-T细胞、白介素10(IL-10)及转化生长因子β1(TGF-β1)含量;分析三者含量与肿瘤分期的相关性,并以肾错构瘤患者及正常人作为对照。结果肾癌患者CD8^+CD28^-T细胞、IL-10及TGF-β1均显著高于另外两组,但肾错构瘤患者与正常人之间均无统计学差异(P<0.05);术前III期患者CD8^+CD28^-T细胞、IL-10及TGF-β1显著高于I及II期(P<0.05);术后各期肾癌患者CD8^+CD28^-T细胞及TGF-β1含量均显著低于术前(P<0.05),但IL-10却与术前无统计学差异;术后III期患者CD8^+CD28^-T细胞、IL-10及TGF-β1显著高于Ⅰ及Ⅱ期患者(P<0.05),但术前及术后I及II期患者上述三项指标均无统计学差异。相关性分析显示CD8^+CD28^-T细胞、IL-10及TGF-β1与分期均呈显著正相关性(P<0.05),其相关程度由大至小依次为CD8^+CD28^-T细胞>TGF-β1>IL-10。结论CD8^+CD28^-T细胞及其细胞因子表达含量增多可能是肾癌的一个新免疫机制,前者可在一定程度上鉴别肾癌与良性肿瘤,且可以评价手术效果。 Objective To investigate the expression and clinical significance of CD8 +CD28-T cells for patients with renal carcinoma undergoing nephrectomy. Methods Fifty-two patients who underwent radical prostatectomy were collected as research objects(group A). Flow cytometry was used to test peripheral blood CD8+CD28-T cells before and after operation, interleukin 10(IL-10), and transforming growth factor beta 1(TGF-beta 1) content. The correlation between the three levels and of tumor stage was analyzed. The patients with renal hamartoma(group B) and normal people(group C) served as controls. Results The CD8+CD28-T cells number, expression of IL-10 and TGF-beta 1 in group A were significantly higher than the other two groups, but had no statistical difference between the group B and group C. Preoperative levels of CD8+CD28-T cells, IL-10 and TGF-beta 1 in the patients with stage III were significantly higher than those with stage I and stage II(P 0.05). Postoperative levels of CD8+CD28-T cells,IL-10 were increased and TGF-beta 1 content was decreased in patients with stage III than that of preoperative period(P 0.05), but no difference in patients with stage I and stage II between pre- and post-operation. Correlation analysis showed that the CD8+CD28-T cells,IL-10 and TGF-beta 1 and tumor stage showed significant positive correlation(P 0.05) and the related degree was CD8+CD28-T cells TGF-beta 1 IL-10. Conclusion The increases of CD8+CD28-T cells and cytokines levels could be a new immune mechanism of kidney carcinoma, and the former could identify kidney cancer and benign tumor, evaluate the operation effect.
出处 《岭南现代临床外科》 2015年第2期219-221,共3页 Lingnan Modern Clinics in Surgery
关键词 肾癌 CD8^+CD28^-T细胞 分期 流式细胞术 Renal carcinoma CD8+CD28-T cells Tumor Stage Flow cytometry
  • 相关文献

参考文献10

二级参考文献82

  • 1齐巍,赵继宗,王硕,王嵘.免疫炎性反应与颅内囊性动脉瘤基质重塑的组织病理学研究[J].首都医科大学学报,2004,25(4):461-463. 被引量:10
  • 2陈中,严以群,吴孟超.CD4^+CD25^+调节性T细胞在肿瘤免疫中的作用[J].中国肿瘤,2005,14(11):729-732. 被引量:3
  • 3陈丽娜,王聪华,朱平,樊春梅,王彦宏,李小燕.CD4^+CD25^(high)调节性T细胞在类风湿性关节炎病程中的消长及其意义[J].细胞与分子免疫学杂志,2007,23(4):331-334. 被引量:13
  • 4Rizzello V, Huzzo G, Brugaletta S, et al. Modulation of CD4+ CD28null T lymphocytes by tumor neerosia factor-alpha blockade in patients with unstable angina[ J]. Circulation, 2006,113(19) :22-27.
  • 5Murphy TJ, Choileain NN, Zang Y, et al. CD4^+ CD25 ^+ regulatory T cells control innate immune reactivity after injury [ J ]. J Immunol, 2005, 174(5) :2957-2963.
  • 6Van Amelsfort JM, Jaeobs KM, Bijlsma JW, et al. CD4 + CD25 +regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid[ J]. Arthritis Rheum, 2004, 50(9) :2775-2785.
  • 7Najafian N, Chitni S, Salama AD, et al. Regulatory CD8 ^+ CD28^ - T cells in an autoimmune disease model[J]. J Clin Invest, 2003,112(7) :1037-1048.
  • 8Suciu-Foca N, Manavalan JS, Cortesini R. Generation and function of antigen specific suppressor and regulatory T cells[ J]. Transpl Immunol, 2003,11(3-4) :235-244.
  • 9Molteni M, Rossetti C, Scrofani S, et al. Regulatory CD8 + T cells control thyrotropin receptor-specific CD4 + clones in healthy subjects[J]. Cancer Detect Prev, 2003,27(3) :167-174.
  • 10Ljungberg B, Hanbury DC, Kuczyk MA, et al. Renal cell carcinoma guideline. Eur Urol, 2007, 51:1502-1510.

共引文献41

同被引文献28

  • 1LU Y,TIANYONG F,QIANG W,et al.Early immune outcome of retroperitoneal laparoscopic radical nephrectomy for localized renal cell carcinoma:a prospective,randomized study[J].Can Urol Assoc J,2012,6(6);E242-248.
  • 2LI Y,GUO Z,LIU CF,et al.Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma[J].Cryobiology,2012,65(1):56-59.
  • 3WEISS JM,GREGORY ALVORD W,QUI ONES OA,et al.CD40 expression in renal cell carcinoma is associated with tumor apoptosis,CD8(+) T cellfrequency and patient survival[J].Hum Immunol,2014,75(7):614-620.
  • 4AMIN A,DUDEK AZ( LOGAN TF,et al.Survival with AGS-003,an autologous dendritic cell-based immunotherapy,in com- bination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC):Phase 2 study results[J].J Im- munotherCancer,2015,21(3):e14.
  • 5MELLA M,KAUPPILA JH,KARIHTALA P,et al.Tumor in- filtrating CD8<sup>+</sup> T lymphocyte count is indepen- dent of tumor TLR9 status in treatment na ve triple negative breast cancer and renal cell carcinoma[J],Oncoim- munology,2015,4(6):e1002726.
  • 6孟庆泽,乔保平,宫璀璀,刘德海,张喜卿,李琦,马志远,董新强.肾透明细胞癌组织中T细胞淋巴瘤侵袭和转移诱导蛋白1表达及其临床意义[J].中华泌尿外科杂志,2011,32(12):815-818. 被引量:6
  • 7高锐,张诚.肾癌预后分子生物标记物研究进展[J].现代生物医学进展,2012,12(14):2781-2784. 被引量:2
  • 8刘伟,刘任功,罗辉,赵亚昆,仇宇,祝清国.监测肾癌患者外周血CD4^+CD25^+调节性T细胞在术后免疫治疗中的作用[J].现代肿瘤医学,2012,20(8):1649-1652. 被引量:19
  • 9吴乐军,戎瑞明,吴应虬,陈谷泉.肾癌各期患者调节性T细胞的表达[J].全科医学临床与教育,2012,10(4):370-372. 被引量:7
  • 10李小攀,杨黎明,孙乔,杨琛,闫蓓,张美玉,李晓莉,吴铮,孙良红.上海市浦东新区居民肾癌患者生存率影响因素分析[J].中华肿瘤防治杂志,2013,20(21):1634-1637. 被引量:10

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部